NG BIOTECH – Trademark Portfolio
Entity Type: 03
NG BIOTECH holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include NG-TEST, NG BIOTECH, NG PRECISION +, and EASY SYSTEM NG.BIOTECH. The owner is based in GUIPRY-MESSAC.
Atelier Relais le Tremplin Guipry
Parc d'Activité de Courbouton Sect 1
GUIPRY-MESSAC 35480 , FR
Showing of trademarks Trademarks
Trademark Classifications
NG BIOTECH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does NG BIOTECH have?
NG BIOTECH has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does NG BIOTECH file in?
NG BIOTECH files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are NG BIOTECH's most well-known trademarks?
NG BIOTECH's registered trademark portfolio includes well-known marks such as NG-TEST, NG BIOTECH, NG PRECISION +, and EASY SYSTEM NG.BIOTECH. These are among 4 currently registered trademarks in the portfolio.
What is NG BIOTECH's trademark registration success rate?
NG BIOTECH has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.